Forty-eight week efficacy and safety of pegcetacoplan in adult patients with paroxysmal nocturnal hemoglobinuria and suboptimal response to prior eculizumab treatment
HemaSphere
; 5(SUPPL 2):42-43, 2021.
Article
in English
| EMBASE | ID: covidwho-1393439
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
HemaSphere
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS